We are international
Donate
TEXT SIZE   


Phase 2 Study of Carfilzomib in Patients with Relapsed Myeloma (PX-171-004)
By Ravi Vij, M.D.
IIth International Myeloma Workshop in Washington, DC
Ravi Vij, M.D.
Washington University School of Medicine
Saint Louis, Missouri
02.23.09



XIIth International Myeloma Workshop in Washington, DC - On-Demand Only
Session: Clinical - New Agents
Chairs: Alok Sharma, M.D., Meletios Dimopoulos, M.D.

February 27, 2009, 14:15 - 14:30 Eastern Standard Time


Phase 2 Study of Carfilzomib in Patients with Relapsed Myeloma (PX-171-004)
Dr. Ravi Vij
Washington University School of Medicine, Saint Louis, Missouri

 


Back to the Meeting Index


 related articles